tirzepatide surmount-1 weight loss percent 72 weeks reduction over time in tirzepatide‐treated participants by early weight response: Post hoc analysis in SURMOUNT‐1 - Ard - 2025 - Diabetes, Obesity and Metabolism SURMOUNT-1 Trial - Cardionerds Twitter

While these drugs, which mimic the effects of the hormone GLP-1 by slowing stomach emptying and promoting a feeling of fullness, are often viewed as a quick solution, rapid weight loss is associated with bone density reduction, as the reduced load the weight, pressure or stress your bones have to bear decreases the need to form new skeletal tissue, as the more pressure on your bones, the more your bones are forced to become stronger

Front Plant Sci 11:543747 Khaksar G, Sirikantaramas S (2021) Transcriptome-wide identification and expression profiling of the ERF gene family suggest roles as transcriptional activators and repressors of fruit ripening in durian

However, tirzepatide is not suitable for everyone

Fundus photography captures color pictures of your retina for comparison at future visits

Villanueva V, Li X, Jimenez V, Faridi HM, Gupta V

Therefore, the practice of microdosing GLP-1 medications is experimental and off-label and is not approved by the FDA